These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Idiotypes and autoimmunity. Male DK Clin Exp Immunol; 1986 Jul; 65(1):1-9. PubMed ID: 3098469 [No Abstract] [Full Text] [Related]
23. Breakdown of self-tolerance in anergic B lymphocytes. Goodnow CC; Brink R; Adams E Nature; 1991 Aug; 352(6335):532-6. PubMed ID: 1830923 [TBL] [Abstract][Full Text] [Related]
24. [Is immune complex glomerulonephritis due to idiotypic interactions between immunoglobulin molecules?]. Lambert PH; Goldman M; Rose LM Nephrologie; 1982; 3(3):109-10. PubMed ID: 6983041 [No Abstract] [Full Text] [Related]
25. Diseases of autoimmunity. Dixon FJ Natl Cancer Inst Monogr; 1982; 60():181-92. PubMed ID: 6214718 [No Abstract] [Full Text] [Related]
26. [Disorders of cellular immunity in systemic scleroderma]. Sierakowski SJ; Kucharz EJ Przegl Lek; 1988; 45(7):592-7. PubMed ID: 3070641 [No Abstract] [Full Text] [Related]
27. Self-tolerance and autoimmunity. Allison AC; Denman AM Br Med Bull; 1976 May; 32(2):124-9. PubMed ID: 782632 [No Abstract] [Full Text] [Related]
28. T and B cell connections in experimentally induced autoimmunity. Male DK; Pryce G; Cooke A; Hutchings P; Marshall-Clarke S; Roitt IM Ann N Y Acad Sci; 1986; 475():94-105. PubMed ID: 3491568 [No Abstract] [Full Text] [Related]
29. Idiotype-specific helper cells (BH) express immunoglobulin markers and employ T cell function-associated molecules. Sherr DH; Ju ST J Immunol; 1986 Dec; 137(11):3406-13. PubMed ID: 2946760 [TBL] [Abstract][Full Text] [Related]
30. The design of regulatory circuitry: predominant idiotypy and the idea of regulatory parsimony. Sercarz EE; Araneo B; Benjamin CD; Harvey M; Metzger D; Miller A; Wicker L; Yowell R Ann N Y Acad Sci; 1983; 418():198-205. PubMed ID: 6201103 [No Abstract] [Full Text] [Related]
33. Induction of immunoglobulin-secreting cells by 2-mercaptoethanol in in vitro culture of B cells from autoimmune mice. Fujiwara M; Kariyone AI Immunology; 1984 Apr; 51(4):801-8. PubMed ID: 6231244 [TBL] [Abstract][Full Text] [Related]
34. [Current status of monoclonal antibodies in autoimmune diseases and problems associated with their clinical application]. Horiuchi A Nihon Rinsho; 1983; 41(4):830-3. PubMed ID: 6350652 [No Abstract] [Full Text] [Related]
35. [Mechanism of autoantibody production]. Yamauchi K Nihon Rinsho; 1983; 41(4):722-5. PubMed ID: 6604177 [No Abstract] [Full Text] [Related]
36. [Autoaggression and self tolerance. The pathogenesis of autoimmune diseases]. Begemann M Med Klin; 1981 Feb; 76(5):118-27. PubMed ID: 6452569 [No Abstract] [Full Text] [Related]
38. [Self-tolerance and autoimmunity. A new concept and its significance]. Wekerle H; Cohen IR; Feldman M Dtsch Med Wochenschr; 1974 Aug; 99(35):1734-9. PubMed ID: 4277922 [No Abstract] [Full Text] [Related]
39. The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation. Mitchison NA Eur J Immunol; 1971 Jan; 1(1):18-27. PubMed ID: 14978857 [No Abstract] [Full Text] [Related]
40. Comparison of antigen-specific T cell responses in autoimmune MRL/Mp-lpr/lpr and MRL/Mp-+/+ mice. Scott CF; Tsurufuji M; Lu CY; Finberg R; Sy MS J Immunol; 1984 Feb; 132(2):633-9. PubMed ID: 6197469 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]